Relief Therapeutics files Form 20-F with the SEC

seekingalpha2021-12-16

Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC. The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

d51293f
2021-12-17
d51293f
Please help to like
Thengz
2021-12-16
Thengz
Ok!
MrHuattt
2021-12-16
MrHuattt
H
- MrHuattt:
  I
lololol13
2021-12-16
lololol13
Noted
hitithard
2021-12-16
hitithard
K
- pkycme:
  F
- lololol13:
  k
yyhwin
2021-12-16
yyhwin
hi

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1131701719?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-16 16:26","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1131701719","market":"us","top_or_hot":-1,"title":"Relief Therapeutics files Form 20-F with the SEC","media":"seekingalpha","content":"<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RLFTY","symbol_name":"RELIEF THERAPEUTICS HLDG AG","start_time":0,"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","article_id":"1131701719","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","pubTimestamp":1639643208,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RLFTY":"RELIEF THERAPEUTICS HLDG AG"},"translate_title":"SEC的救济治疗文件格式为20-F","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RLFTY":0.9},"content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":690507128,"gmtCreate":1639676969265,"gmtModify":1639676969337,"author":{"id":"3585403364637520","authorId":"3585403364637520","name":"d51293f","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3585403364637520","idStr":"3585403364637520"},"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690507128","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690139862,"gmtCreate":1639646162516,"gmtModify":1639646163084,"author":{"id":"3579207760920564","authorId":"3579207760920564","name":"Thengz","avatar":"https://static.tigerbbs.com/eb87a2ba614bf594d49c299bab92466e","vip":1,"crmLevel":9,"crmLevelSwitch":0,"authorIdStr":"3579207760920564","idStr":"3579207760920564"},"htmlText":"Ok!","listText":"Ok!","text":"Ok!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690139862","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690195032,"gmtCreate":1639645996747,"gmtModify":1639645997049,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"4089116574465250","idStr":"4089116574465250"},"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690195032","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7003288,"gmtCreate":1639646000370,"gmtModify":1639646000399,"authorId":4089116574465250,"author":{"id":4089116574465250,"idStr":"4089116574465250","authorId":4089116574465250,"name":"MrHuattt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690195032,"type":1,"supId":0,"prevId":0,"content":"<u>I</u>","text":"<u>I</u>","html":"<u>I</u>"}],"langContent":"CN"},{"id":690375899,"gmtCreate":1639644173311,"gmtModify":1639644173534,"author":{"id":"3583916713249739","authorId":"3583916713249739","name":"lololol13","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3583916713249739","idStr":"3583916713249739"},"htmlText":"Noted&nbsp;","listText":"Noted&nbsp;","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690375899","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690376990,"gmtCreate":1639643877431,"gmtModify":1639643877857,"author":{"id":"3570063321997588","authorId":"3570063321997588","name":"hitithard","avatar":"https://static.tigerbbs.com/309ce7b357018aa7b946332c2fe8725c","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3570063321997588","idStr":"3570063321997588"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690376990","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7002926,"gmtCreate":1639644850696,"gmtModify":1639644850735,"authorId":3572041120390941,"author":{"id":3572041120390941,"idStr":"3572041120390941","authorId":3572041120390941,"name":"pkycme","avatar":"https://static.tigerbbs.com/2c8abf6e02924915f7b31ba778563bcc","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690376990,"type":1,"supId":7002876,"prevId":0,"content":"<u>F</u>","text":"<u>F</u>","html":"<u>F</u>"},{"id":7002876,"gmtCreate":1639644163200,"gmtModify":1639644163305,"authorId":3583916713249739,"author":{"id":3583916713249739,"idStr":"3583916713249739","authorId":3583916713249739,"name":"lololol13","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690376990,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"CN"},{"id":690378778,"gmtCreate":1639643862875,"gmtModify":1639643863225,"author":{"id":"3581931076615563","authorId":"3581931076615563","name":"yyhwin","avatar":"https://static.tigerbbs.com/78727032603c2751ac0b6b6cfb678920","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581931076615563","idStr":"3581931076615563"},"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690378778","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":57,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131701719"}